Skip to main content
OpenTrials

Clinical trial condition

Hemic and Lymphatic Diseases

Explore clinical trials studying Hemic and Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

21,074 public trials 3,988 recruiting studies
Refine in advanced search Browse all conditions

Hemic and Lymphatic Diseases trial results

Recruiting

A Study Evaluating the Safety and Efficacy of Multiple Treatments in Participants With Multiple Myeloma

NCT05583617

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Prince of Wales Hospital Randwick, New South Wales, Australia
  • St Vincent's Hospital Melbourne Fitzroy, Victoria, Australia
  • CHU Lyon Sud - Service Hématologie Pierre-Bénite, France
  • IUCT Oncopole Toulouse, France
View all 16 locations
View Trial Details
Recruiting

Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation

NCT06465953

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • Presbyterian / St. Luke'S Medical Center Denver, Colorado, United States
  • University of Chicago, Duchossois Center for Advanced Medicine (DCAM) Chicago, Illinois, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • MSKCC New York, United States
View all 62 locations
View Trial Details
Recruiting

A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)

NCT07634471

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • SCRI Oncology Partners ( Site 7000) Nashville, Tennessee, United States
  • Hadassah Medical Center ( Site 0701) Jerusalem, Israel
  • Sheba Medical Center ( Site 0702) Ramat Gan, Israel
  • Sourasky Medical Center ( Site 0704) Tel Aviv, Israel
View all 24 locations
View Trial Details
Recruiting

A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma

NCT06084936

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations
  • Alta Bates Summit Medical Center Berkeley, California, United States
  • City of Hope Cancer Center Duarte, California, United States
  • University of California Los Angeles (UCLA) - Cancer Care - Santa Monica Santa Monica, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 82 locations
View Trial Details
Recruiting

A Study on the Tolerability, Safety and Effectiveness of Asciminib in Patients With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in the Chronic Phase in Germany

NCT07549516

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations
  • Novartis Investigative Site Baden-Baden, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Heidenheim, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Schwäbisch Hall, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Aschaffenburg, Bavaria, Germany
View all 65 locations
View Trial Details
Recruiting

A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)

NCT06514794

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • City of Hope Duarte, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • H. Lee Moffitt Cancer Center and Research Institute Hospital Tampa, Florida, United States
View all 18 locations
View Trial Details
Recruiting

Toxin Exposure and Immune Dysregulation in Non-Hodgkin Lymphoma

NCT07652580

Conditions
B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune Dysregulation, +12 more
Locations
  • Uniformed Services University of the Health Sciences Bethesda, Maryland, United States
  • Walter Reed National Military Medical Center Bethesda, Maryland, United States
  • Naval Medical Center Portsmouth Portsmouth, Virginia, United States
View Trial Details
Recruiting

Mindfulness-Based Cognitive Therapy (MBCT) for the Prevention of Depression Relapse or Recurrence Using Videoconference

NCT06832605

Conditions
Behavior, Behavioral Symptoms, Depression, +21 more
Locations
  • Parc de Salut Mar Barcelona, Spain
  • Parc Sanitari Sant Joan de Déu (PSSJD) Sant Boi de Llobregat, Barcelona, Spain
  • Hospital Universitario Miguel Servet Zaragoza, Spain
  • Hospital General Universitario de Elche Elche, Alicante, Spain
View Trial Details

Related conditions